major-depressive-disorder

Documents about major-depressive-disorder

• Chart Review of Patients Undergoing Ketamine Infusions#911387ClinicalTrials.gov
• A Biological Signature for the Early Differential Diagnosis of Psychosis#866260ClinicalTrials.gov
• Alexithymia Intervention for Suicide#909661ClinicalTrials.gov
• Online Writing Intervention for Major Depressive Disorder#880296ClinicalTrials.gov
• Differential Efficacy of Supportive and Interpretative Psychodynamic Techniques for Dependent and Self-critical Depressive Patients#836777ClinicalTrials.gov
• The Safety, Efficacy, and Tolerability of Microbial Ecosystem Therapeutic-2 in People With Major Depression#878920ClinicalTrials.gov
• N-methylglycine (Sarcosine) Treatment for Depression#914050ClinicalTrials.gov
• A Clinical Trial of Add-on Oral Slow-release Ketamine Treatment in Major Depression#968912ClinicalTrials.gov
• Nitrous Oxide as Treatment for Major Depression - a Pilot Study#982651ClinicalTrials.gov
• Cognitive functioning in first episode and recurrent major depressive disorder: A systematic review and meta-analysis of comparative performance.#447086ULRR
• A Study in Participants With Major Depressive Disorder (MDD) With Anhedonia and Inadequate Response to Current Antidepressant Therapy Including a Selective Serotonin Reuptake Inhibitor (SSRI) or Serotonin Norepinephrine Reuptake Inhibitor (SNRI)#994747ClinicalTrials.gov
• Concurrent fMRI-guided rTMS and Cognitive Therapy for the Treatment of Major Depressive Episodes#915699ClinicalTrials.gov
• Clinical and Suicidal Features of Urban, Turkish Middle Age Depressive Patients With Comorbid ADHD#827603ClinicalTrials.gov
• Efficacy and Safety of Duloxetine Among Individuals With Depressive Disorder in a 12 Weeks Trial#890995ClinicalTrials.gov
• A United States Study of Corlux for Psychotic Symptoms in Psychotic Major Depression#804915ClinicalTrials.gov
• Biomarkers of ANTidepressant RESponse and Development Risk of Bipolar Disorder#1031955ClinicalTrials.gov
• Pharmacogenomics of Major Depressive Disorder in Indigenous Amazonian Populations.#25923NCBI PubMed Central
• Spontaneous thought-related network connectivity predicts sertraline effects on major depressive disorder#99110PhilArchive
• Symptom-specific genetics reveal heterogeneity within major depressive disorder#395169Europe PMC
• Alterations in aperiodic neural activity associated with major depressive disorder.#446289NCBI PubMed Central
• Major depressive disorder: From accurate diagnosis to effective treatment through first-person psychopharmacology#688748PhilArchive
• Desvenlafaxine Succinate (Pristiq): Postmarketing Surveillance Study Among Filipino Patients#806724ClinicalTrials.gov
• Sensory Synchronized Imaging and Neuromodulation#811748ClinicalTrials.gov
• A Study of LY2216684 in Healthy Participants#833950ClinicalTrials.gov
• Objective Diagnostic Markers and Personalized Intervention in MDD Patients#841956ClinicalTrials.gov
• Clinical and Biological Characteristics of Psychotic Depression#873325ClinicalTrials.gov
• Does Concurrent Hydrocortisone With Venlafaxine XR Speed Antidepressant Response?#885114ClinicalTrials.gov
• Ketamine in the Treatment of Depression#889692ClinicalTrials.gov
• 5-HTP and Creatine for Depression R33 Phase#912773ClinicalTrials.gov
• A Study of Xiongdan Wan Treating Depression#914383ClinicalTrials.gov
• Switching to Duloxetine in Patients With Depression#968126ClinicalTrials.gov
• Basal Plasma Lithium Levels and Suicidal Events#850963ClinicalTrials.gov
• Family Based Treatment of Depressed Adolescents#855912ClinicalTrials.gov
• A Study of Flexible or Fixed Dose LY2216684 as Adjunctive Treatment for Participants With Major Depressive Disorder Who Have Had a Partial Response to Selective Serotonin Reuptake Inhibitor (SSRI) Treatment#835266ClinicalTrials.gov
• Randomised Placebo-controlled Duloxetine-referenced Study of Efficacy and Safety of 5 mg of Vortioxetine (Lu AA21004) in Acute Treatment of Major Depressive Disorder in Elderly Patients#969653ClinicalTrials.gov
• Efficacy of Vortioxetine (Lu AA21004) in the Prevention of Relapse of Major Depressive Episodes#874481ClinicalTrials.gov
• Brief Multifamily Psychoeducation for Families of Patients With Chronic Major Depression#831726ClinicalTrials.gov
• Pilot Study in Multi-Coil Repetitive Transcranial Magnetic Stimulation (rTMS) for Treatment Resistant Depression#1007269ClinicalTrials.gov
• Single Session of tACS in a Depressive Episode#890740ClinicalTrials.gov
• "Mamá, te Entiendo" App-based Intervention for Reducing Depressive Symptoms in Postpartum Women#910359ClinicalTrials.gov
• Desvenlafaxine vs. Placebo Treatment of Chronic Depression#982703ClinicalTrials.gov
• Cognitive Behavior Therapy Among Patients With Major Depressive Disorder-Multiple Episodes.#888702ClinicalTrials.gov
• Identification and Molecular Characterisation of Urban-environmental Stress Patterns Affecting Mental Illness#897053ClinicalTrials.gov
• The UTHealth Ketamine Project#880516ClinicalTrials.gov
• Individualizing Incentives for Alcohol in the Severely Mentally Ill#899285ClinicalTrials.gov
• Failure to integrate: Connector hub dysfunction in major depressive disorder.#251080NCBI PubMed Central
• Reduced alpha power predicts recurrence risk in major depressive disorder#253564Europe PMC
• Circadian rhythms in major depressive disorder: mechanistic insights and therapeutic frontiers.#262860NCBI PubMed Central
• Identification of Major Depressive Disorder Using Multiple Functional Connection Patterns.#265585NCBI PubMed Central
• Genetic evidence for repurposing immunomodulatory drugs for major depressive disorder#422493Europe PMC